|
1
|
Dimaras H, Kimani K, Dimba EA, Gronsdahl
P, Whit A, Chan HS and Gallie BL: Retinoblastoma. Lancet.
379:1436–1446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kivelä T: The epidemiological challenge of
the most frequent eye cancer: Retinoblastoma, an issue of birth and
death. Br J Ophthalmol. 93:1129–1131. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abramson DH, Beaverson K, Sangani P, Vora
RA, Lee TC, Hochberg HM, Kirszrot J and Ranjithan M: Screening for
retinoblastoma: Presenting signs as prognosticators of patient and
ocular survival. Pediatrics. 112:1248–1255. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Balmer A, Zografos L and Munier F:
Diagnosis and current management of retinoblastoma. Oncogene.
25:5341–5349. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jabbour P, Chalouhi N, Tjoumakaris S,
Gonzalez LF, Dumont AS, Chitale R, Rosenwasser R, Bianciotto CG and
Shields C: Pearls and pitfalls of intraarterial chemotherapy for
retinoblastoma. J Neurosurg Pediatr. 10:175–181. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moss EG: MicroRNAs: Hidden in the genome.
Curr Biol. 12:R138–R140. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kozomara A and Griffiths-Jones S: miRBase:
Integrating microRNA annotation and deep-sequencing data. Nucleic
Acids Res. 39:(Database Issue). D152–D157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Golabchi K, Soleimani-Jelodar R, Aghadoost
N, Momeni F, Moridikia A, Nahand JS, Masoudifar A, Razmjoo H and
Mirzaei H: MicroRNAs in retinoblastoma: Potential diagnostic and
therapeutic biomarkers. J Cell Physiol. 233:3016–3023. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu B, Chen W, Cao G, Dong Z, Xu J, Luo T
and Zhang S: MicroRNA-27b inhibits cell proliferation in oral
squamous cell carcinoma by targeting FZD7 and Wnt signaling
pathway. Arch Oral Biol. 83:92–96. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li P, Dong J, Zhou X, Sun W, Huang H, Chen
T, Ye B, Zheng Z and Lu M: Expression patterns of microRNA-329 and
its clinical performance in diagnosis and prognosis of breast
cancer. Onco Targets Ther. 10:5711–5718. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun X, Wang M, Liu H and Wang J:
MicroRNA-423 enhances the invasiveness of hepatocellular carcinoma
via regulation of BRMS1. Am J Transl Res. 9:5576–5584.
2017.PubMed/NCBI
|
|
14
|
D'Angelo B, Benedetti E, Cimini A and
Giordano A: MicroRNAs: A puzzling tool in cancer diagnostics and
therapy. Anticancer Res. 36:5571–5575. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu Y, Tang Z, Jiang B, Chen J and Fu Z:
miR-198 functions as a tumor suppressor in breast cancer by
targeting CUB domain-containing protein 1. Oncol Lett.
13:1753–1760. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nie E, Jin X, Wu W, Yu T, Zhou X, Shi Z,
Zhang J, Liu N and You Y: MiR-198 enhances temozolomide sensitivity
in glioblastoma by targeting MGMT. J Neurooncol. 133:59–68. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang WT, Wang HL, Yang H, Ren FH, Luo YH,
Huang CQ, Liang YY, Liang HW, Chen G and Dang YW: Lower expressed
miR-198 and its potential targets in hepatocellular carcinoma: A
clinicopathological and in silico study. Onco Targets Ther.
9:5163–5180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang S, Zhao Y and Wang L: MicroRNA-198
inhibited tumorous behaviors of human osteosarcoma through directly
targeting ROCK1. Biochem Biophys Res Commun. 472:557–565. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zou WW and Xu SP: Galangin inhibits the
cell progression and induces cell apoptosis through activating PTEN
and Caspase-3 pathways in retinoblastoma. Biomed Pharmacother.
97:851–863. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gui F, Hong Z, You Z, Wu H and Zhang Y:
MiR-21 inhibitor suppressed the progression of retinoblastoma via
the modulation of PTEN/PI3K/AKT pathway. Cell Biol Int.
40:1294–1302. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, Wan ST, Zhang P, Zhang WX, Zheng
JL, Lin JX and Li YP: Expression levels of autophagy related
proteins and their prognostic significance in retinocytoma and
retinoblastoma. Int J Ophthalmol. 7:594–601. 2014.PubMed/NCBI
|
|
23
|
Liang Y, Chen X and Liang Z: MicroRNA-320
regulates autophagy in retinoblastoma by targeting hypoxia
inducible factor-1α. Exp Ther Med. 14:2367–2372. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang LL, Hu HF and Feng YQ: Suppressive
effect of microRNA-143 in retinoblastoma. Int J Ophthalmol.
9:1584–1590. 2016.PubMed/NCBI
|
|
25
|
Bai S, Tian B, Li A, Yao Q, Zhang G and Li
F: MicroRNA-125b promotes tumor growth and suppresses apoptosis by
targeting DRAM2 in retinoblastoma. Eye (Lond). 30:1630–1638. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang J, Zhao H, Xin Y and Fan L:
MicroRNA-198 inhibits proliferation and induces apoptosis of lung
cancer cells via targeting FGFR1. J Cell Biochem. 115:987–995.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ye L, Li S, Ye D, Yang D, Yue F, Guo Y,
Chen X, Chen F, Zhang J and Song X: Livin expression may be
regulated by miR-198 in human prostate cancer cell lines. Eur J
Cancer. 49:734–740. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qi B, Yao WJ, Zhao BS, Qin XG, Wang Y,
Wang WJ, Wang TY, Liu SG and Li HC: Involvement of microRNA-198
overexpression in the poor prognosis of esophageal cancer. Asian
Pac J Cancer Prev. 14:5073–5076. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tan S, Li R, Ding K, Lobie PE and Zhu T:
miR-198 inhibits migration and invasion of hepatocellular carcinoma
cells by targeting the HGF/c-MET pathway. FEBS Lett. 585:2229–2234.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu S, Zhang G, Li P, Chen S, Zhang F, Li
J, Jiang C, Chen X, Wang Y, Du Y, et al: miR-198 targets SHMT1 to
inhibit cell proliferation and enhance cell apoptosis in lung
adenocarcinoma. Tumour Biol. 37:5193–5202. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Dan G, Shangguan T, Hao H, Tang R,
Peng K, Zhao J, Sun H and Zou Z: miR-198 represses the
proliferation of HaCaT cells by targeting cyclin D2. Int J Mol Sci.
16:17018–17028. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fei G, Ebert MP, Mawrin C, Leodolter A,
Schmidt N, Dietzmann K and Malfertheiner P: Reduced PTEN expression
in gastric cancer and in the gastric mucosa of gastric cancer
relatives. Eur J Gastroenterol Hepatol. 14:297–303. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Koksal IT, Yasar D, Dirice E, Usta MF,
Karauzum S, Luleci G, Baykara M and Sanlioglu S: Differential PTEN
protein expression profiles in superficial versus invasive bladder
cancers. Urol Int. 75:102–106. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Loures LF, Cândido EB, Vidigal PV, Seabra
MA, Marco LA and Silva-Filho AL: PTEN expression in patients with
carcinoma of the cervix and its association with p53, Ki-67 and
CD31. Rev Bras Ginecol Obstet. 36:205–210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li Y, Li Y, Yang H and Wang P: Expressions
and significance of PTEN and LKB1 in non-small cell lung cancer.
Sichuan Da Xue Xue Bao Yi Xue Ban. 47:507–511. 2016.PubMed/NCBI
|
|
36
|
de Araujo WM, Robbs BK, Bastos LG, de
Souza WF, Vidal FC, Viola JP and Morgado-Diaz JA: PTEN
overexpression cooperates with lithium to reduce the malignancy and
to increase cell death by apoptosis via PI3K/Akt suppression in
colorectal cancer cells. J Cell Biochem. 117:458–469. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu H, Pan Y, Han X, Liu J and Li R:
MicroRNA-216a promotes the metastasis and epithelial-mesenchymal
transition of ovarian cancer by suppressing the PTEN/AKT pathway.
Onco Targets Ther. 10:2701–2709. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Koul D, Shen R, Garyali A, Ke LD, Liu TJ
and Yung WK: MMAC/PTEN tumor suppressor gene regulates vascular
endothelial growth factor-mediated angiogenesis in prostate cancer.
Int J Oncol. 21:469–475. 2002.PubMed/NCBI
|
|
39
|
Tao J, Xiong J, Li T, Yang Z, Li X, Li K,
Wu H and Wang C: Correlation between protein expression of PTEN in
human pancreatic cancer and the proliferation, infiltration,
metastasis and prognosis. J Huazhong Univ Sci Technolog Med Sci.
26:444–447. 2006. View Article : Google Scholar : PubMed/NCBI
|
